Smart contact lens monitors eye pressure and delivers glaucoma drugs in early tests - Summary - MDSpire

Smart contact lens monitors eye pressure and delivers glaucoma drugs in early tests

  • By

  • Annalisa Merelli

  • April 8, 2026

  • 0 min

Share

Objective:

To present a new theranostic contact lens that monitors intraocular pressure (IOP) and administers glaucoma medications, combining therapeutic and diagnostic capabilities.

Key Findings:
  • The lens can monitor IOP and release medication in response to pressure changes.
  • It is designed for comfort and flexibility, unlike existing bulky or electronic options, making it more user-friendly.
  • The device has potential for lower costs compared to current treatments.
Interpretation:

The new contact lens could improve glaucoma management by providing real-time monitoring and addressing medication adherence issues.

Limitations:
  • The drug release mechanism may not provide immediate effects due to the slow action of glaucoma medications, which could delay treatment.
  • Regulatory approval for the drug dispensing system may take longer than for the monitoring system.
Conclusion:

The device represents a significant advancement in glaucoma treatment, with potential applications in other medical fields, including ocular, neurological, and systemic diseases.

Original Source(s)

Related Content